5-(4-Bromo-phenyl)-4-methyl-4H-[1,2,4]triazole-3-thiol, 95.0%, 1g

5-(cyclopentylmethyl)-1,3,4-thiadiazol-2-amine, 95.0%, 250mg

4-Fluoro-1,3-dihydrobenzoimidazol-2-one, 95.0%, 100mg

2-Ethyl-4-fluoro-1-nitrobenzene, 97%, 1g

5-ACETYLTHIOPHENE-2-CARBOXAMIDE, 95%, 250mg

2-(1,3,2-Dioxaborinan-2-yl)benzamide, 97%, 1g

4,4,4',4'-Tetramethyl-2,2'-spirobi[chroman]-7,7'-diol, 99%, 5g

2-Hydroxyethyl phenyl sulfide, 99.0%, 25g

N1-(4-Methylpentan-2-yl)-N4-phenylbenzene-1,4-diamine, 95.0%, 500g

Diethylenetriamine, min. 98%, for synthesis, 1L, glass packaging

HPLC column NUCLEODUR® 100-3 C18 ec 3 µm, 150 mm, 4.6 mm, 1 Piece(s)

4-chloro-2-fluoro-2'-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g

(R)-1-(2-Chlorophenyl)ethanamine hydrochloride, 95.0%, 250mg